Thisis going to be a very key earnings week. The only DJIA component to report its Q3 period report so far has been Alcoa Inc. (NYSE: AA). But we have earnings this week…
We may have had earnings season officially start with Alcoa this week, but next week will be the real week for the launch of earnings season. We now have an index to…
Volume Spike Investor is watching some stocks which should move at the open. These include Johnson & Johnson (JNJ) (details), CIT (CIT) (details), Hoku Scientific (HOKU) (details), China-Biotics (CHBT), and and TerreStar Networks…
Reuters:Â Â China celebrated 60 years of communist rule as a capitalist economy. Reuters:Â Â The IMF cut global debt write-offs to $3.4 trillion. Reuters:Â Â CIT (CIT) is close to a deal to give…
Reuters:  Solvay sold its drug unit to Abbott (ABT) foe $6.6 billion. Reuters:  Kraft (KFT) will launch a hostile bid for Cadbury. Reuters:  The World Bank said not to take the dollar’s…
Reuters:Â Â Obama is trying to push Wall St. reform. Reuters:Â Â German aid for Opel will go in part to Russia for operations there. Reuters:Â Â A global poll shows support for stimulus packages.…
Several consulting firms post annual figures for the world’s most valuable brands. The two best known are probably the Interbrand and BrandZ surveys. They are notably different, up until now at least.…
Now that we are out of the woods in the crash scenario, assuming this week is no ill omen, investors may want to know which of the big companies would start to…
Wasn’t it just last week that we were up eight days in a row on the DJIA? And now we have a sell-the-news reaction to the recent growth numbers. Maybe it is…
Reuters:Â Â UBS (UBS) shares may fall when the Swiss government sells out. Reuters:Â Â The US deficit estimate was trimmed to $1.59 trillion. Reuters:Â Â A homeowner sued Wells Fargo (WFC) over a credit…
Berkshire Hathaway Inc. (NYSE: BRK-A)(BRK-B) has released its Q2-2009 public equity holdings as of June 30, 2009. There are some portfolio changes that have been seen here from the end of Q1…
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed together. The Medarex…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…
Reuters:Â Â The US may give CIT (CIT) short term loans. Reuters:Â Â Intel (INTC) issued a positive forecast and indicated that the PC market may be improving. Reuters:Â Â The US CPI was up…
DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates. The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues were down…
Douglas A. McIntyre 